Cleared Traditional

K911556 - ANTIMICROBIAL SUSCEPT. TEST PANEL TICAR...

K911556 is an FDA 510(k) clearance for ANTIMICROBIAL SUSCEPT. TEST PANEL TICAR..., manufactured by Alamar Biosciences Laboratory, Inc.. The device is a Class 2 Microbiology device with product code JWY cleared through the Traditional 510(k) pathway after a 14-day FDA review.

K911556 · Alamar Biosciences Laboratory, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1991
Decision
14d
Days
Class 2
Risk

K911556 is an FDA 510(k) clearance for the ANTIMICROBIAL SUSCEPT. TEST PANEL TICARC./CLAVUL.. Classified as Manual Antimicrobial Susceptibility Test Systems (product code JWY), Class II - Special Controls.

Submitted by Alamar Biosciences Laboratory, Inc. (Sacramento, US). The FDA issued a Cleared decision on April 22, 1991 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1640 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Alamar Biosciences Laboratory, Inc. devices

FDA 510(k) Submission Details - K911556

510(k) Number K911556 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 08, 1991
Decision Date April 22, 1991
Days to Decision 14 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
88d faster than avg
Panel avg: 102d · This submission: 14d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JWY Device Classification - Class 2, Special Controls

Product Code JWY Manual Antimicrobial Susceptibility Test Systems
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.1640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - JWY Manual Antimicrobial Susceptibility Test Systems

All 391
Devices cleared under the same product code (JWY) and FDA review panel - the closest regulatory comparables to K911556.
ANTIMICROBIAL TOBRAMYCIN
K911304 · Alamar Biosciences Laboratory, Inc. · Apr 1991
ANTIMICROBIAL GENTAMICIN
K911305 · Alamar Biosciences Laboratory, Inc. · Apr 1991
ANITIMICROBIAL SUSCEPT. TEST PANEL AMOX./CLAVUL.
K911555 · Alamar Biosciences Laboratory, Inc. · Apr 1991
ANTIMICROBIAL SUSCEPT. TEST PANEL TICARCILLIN
K911557 · Alamar Biosciences Laboratory, Inc. · Apr 1991
ANTIMICROBIAL SUSCEPT. TEST PANEL CEFONICID
K911559 · Alamar Biosciences Laboratory, Inc. · Apr 1991
ANTIMICROBIAL AMIKACIN
K911303 · Alamar Biosciences Laboratory, Inc. · Apr 1991